1590 related articles for article (PubMed ID: 24595776)
1. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
[TBL] [Abstract][Full Text] [Related]
2. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
3. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
[TBL] [Abstract][Full Text] [Related]
4. Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.
Jun M; James MT; Ma Z; Zhang J; Tonelli M; McAlister FA; Manns BJ; Ravani P; Quinn RR; Wiebe N; Perkovic V; Wilton SB; Winkelmayer WC; Hemmelgarn BR;
Am J Kidney Dis; 2017 Jun; 69(6):734-743. PubMed ID: 27998624
[TBL] [Abstract][Full Text] [Related]
5. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
Dahal K; Kunwar S; Rijal J; Schulman P; Lee J
Chest; 2016 Apr; 149(4):951-9. PubMed ID: 26378611
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical valve prosthesis: A nationwide population-based study.
Labaf A; Svensson PJ; Renlund H; Jeppsson A; Själander A
Am Heart J; 2016 Nov; 181():1-9. PubMed ID: 27823679
[TBL] [Abstract][Full Text] [Related]
7. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
8. Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation: An Observational Cohort Study.
Bonde AN; Lip GY; Kamper AL; Fosbøl EL; Staerk L; Carlson N; Torp-Pedersen C; Gislason G; Olesen JB
Stroke; 2016 Nov; 47(11):2707-2713. PubMed ID: 27758943
[TBL] [Abstract][Full Text] [Related]
9. Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease.
Carrero JJ; Varenhorst C; Jensevik K; Szummer K; Lagerqvist B; Evans M; Spaak J; Held C; James S; Jernberg T
Kidney Int; 2017 Jan; 91(1):216-226. PubMed ID: 27865441
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GYH
Chest; 2014 Jun; 145(6):1370-1382. PubMed ID: 24356875
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
[TBL] [Abstract][Full Text] [Related]
12. Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.
Shin JI; Secora A; Alexander GC; Inker LA; Coresh J; Chang AR; Grams ME
Clin J Am Soc Nephrol; 2018 Aug; 13(8):1144-1152. PubMed ID: 30002224
[TBL] [Abstract][Full Text] [Related]
13. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
Hess CN; Peterson ED; Peng SA; de Lemos JA; Fosbol EL; Thomas L; Bhatt DL; Saucedo JF; Wang TY
J Am Coll Cardiol; 2015 Aug; 66(6):616-27. PubMed ID: 26248987
[TBL] [Abstract][Full Text] [Related]
14. Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.
Eikelboom JW; Connolly SJ; Gao P; Paolasso E; De Caterina R; Husted S; O'Donnell M; Yusuf S; Hart RG
J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):429-35. PubMed ID: 22818021
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study.
Go AS; Singer DE; Toh S; Cheetham TC; Reichman ME; Graham DJ; Southworth MR; Zhang R; Izem R; Goulding MR; Houstoun M; Mott K; Sung SH; Gagne JJ
Ann Intern Med; 2017 Dec; 167(12):845-854. PubMed ID: 29132153
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.
Held C; Hylek EM; Alexander JH; Hanna M; Lopes RD; Wojdyla DM; Thomas L; Al-Khalidi H; Alings M; Xavier D; Ansell J; Goto S; Ruzyllo W; Rosenqvist M; Verheugt FW; Zhu J; Granger CB; Wallentin L
Eur Heart J; 2015 May; 36(20):1264-72. PubMed ID: 25499871
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis.
Hijazi Z; Hohnloser SH; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Siegbahn A; Yusuf S; Wallentin L
Circulation; 2014 Mar; 129(9):961-70. PubMed ID: 24323795
[TBL] [Abstract][Full Text] [Related]
18. Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries.
Bonde AN; Lip GYH; Kamper AL; Staerk L; Torp-Pedersen C; Gislason G; Olesen JB
Thromb Haemost; 2017 Dec; 117(12):2291-2299. PubMed ID: 29212117
[TBL] [Abstract][Full Text] [Related]
19. Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis.
Chan PH; Huang D; Yip PS; Hai J; Tse HF; Chan TM; Lip GY; Lo WK; Siu CW
Europace; 2016 May; 18(5):665-71. PubMed ID: 26504109
[TBL] [Abstract][Full Text] [Related]
20. Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial.
Bohula EA; Giugliano RP; Ruff CT; Kuder JF; Murphy SA; Antman EM; Braunwald E
Circulation; 2016 Jul; 134(1):24-36. PubMed ID: 27358434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
